Sujin (Mary) Jung has served as Director of Clinical Research at Tau Medical since 2014, following the completion of her Master’s degree in Biomaterials Engineering. In her role, she leads and coordinates a broad range of activities across clinical trials, national cardiovascular device development projects, and regulatory compliance.

​

Mary brings extensive hands-on experience in the execution of clinical studies, along with a strong command of intellectual property management and quality assurance in accordance with Korean Good Manufacturing Practice (KGMP) standards under the Ministry of Food and Drug Safety (KFDA).

​

Her multidisciplinary expertise ensures that Tau’s clinical operations meet the highest standards of regulatory rigor, scientific integrity, and patient-centered outcomes.

​

​